NETHERLANDS |AS |EUR
|Public Float||29.81M||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||97.39%||Ex-Dividend Date|
|Held by Institutions||4.45%||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Dec 20||Sep 20||Jun 20|
Kiadis pharma trades on the Euronext Amsterdam stock market in Netherlands under the ticker symbol "KDS". Kiadis pharma’s stock symbol can also be displayed as "AMS:KDS".
Kiadis pharma (AMS:KDS) is owned by 4.45% institutional shareholders and by 97.39% insiders. The rest is owned by the public.
Explore More Details on Kiadis pharma's “Ownership” Section
Kiadis pharma's key executive team includes the following managers:
Kiadis pharma (AMS:KDS) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Kiadis pharma is 103.
Kiadis pharma (AMS:KDS) is headquartered in Netherlands.
Kiadis pharma’s mailing address is Paasheuvelweg 25A, Amsterdam, Netherlands, 1105 BP.
The company’s phone number is 31 20 240 5250.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.